The efficacy of Adapalene (cas 106685-40-9)-benzoyl peroxide combination increases with number of acne lesions
-
Add time:08/08/2019 Source:sciencedirect.com
BackgroundThere is no direct correlation between acne severity and lesion numbers and patients with moderate acne may present with varying lesion counts. The fixed-dose adapalene 0.1%-benzoyl peroxide (BPO) 2.5% combination gel is an efficacious and safe acne treatment.
We also recommend Trading Suppliers and Manufacturers of Adapalene (cas 106685-40-9). Pls Click Website Link as below: cas 106685-40-9 suppliers
Prev:Efficacy of 0.1% Adapalene (cas 106685-40-9) in a non-inflammatory Kyoto Rhino Rat acne model
Next:Effects of thiastearic acids on growth and on dihydrosterculic acid and other phospholipid fatty acyl groups of Leishmania promastigotes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Efficacy of 0.1% Adapalene (cas 106685-40-9) in a non-inflammatory Kyoto Rhino Rat acne model08/07/2019
- Adapalene (cas 106685-40-9) Microemulsion for Transfollicular Drug Delivery08/06/2019
- Incorporation of benzoyl peroxide nanocrystals into Adapalene (cas 106685-40-9)-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide08/05/2019
- Delivery of Adapalene (cas 106685-40-9) using a novel topical gel based on tea tree oil nano-emulsion: Permeation, antibacterial and safety assessments08/04/2019
- Development and characterization of polymeric nanoparticle-based formulation of Adapalene (cas 106685-40-9) for topical acne therapy08/03/2019
- Adapalene (cas 106685-40-9) suppressed the proliferation of melanoma cells by S-phase arrest and subsequent apoptosis via induction of DNA damage08/02/2019
- Lipid and polymer blended polyester nanoparticles loaded with Adapalene (cas 106685-40-9) for activation of retinoid signaling in the CNS following intravenous administration08/01/2019